kwic
who
who
right
off
ON
323
1
100
500
strict
ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for who out of >500 occurrences
271863 occurrences (No.95 in the rank) during 5 years in the PubMed. [no cache] 500 found
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to who]
271863 occurrences (No.95 in the rank) during 5 years in the PubMed. [no cache] 500 found
| 323) Recently, the World Health Organization (WHO) has recommended the development of mathematical models for understanding better antimalarial drug resistance and management. |
| PMID:24251882 DOI:10.1111/bcp.12288 |
| 2015 British journal of clinical pharmacology |
| * Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges. |
| - Malaria remains a global public health concern and current treatment options are suboptimal in some clinical settings. For effective chemotherapy, antimalarial drug concentrations must be sufficient to remove completely all of the parasites in the infected host. Optimized dosing therefore requires a detailed understanding of the time course of antimalarial response, whilst simultaneously considering the parasite life cycle and host immune elimination. Recently, the World Health Organization (WHO) has recommended the development of mathematical models for understanding better antimalarial drug resistance and management. Other international groups have also suggested that mechanistic pharmacokinetic (PK) and pharmacodynamic (PD) models can support the rationalization of antimalarial dosing strategies. At present, artemisinin-based combination therapy (ACT) is recommended as first line treatment of falciparum malaria for all patient groups. This review summarizes the PK-PD characterization of artemisinin derivatives and other partner drugs from both preclinical studies and human clinical trials. We outline the continuous and discrete time models that have been proposed to describe antimalarial activity on specific stages of the parasite life cycle. The translation of PK-PD predictions from animals to humans is considered, because preclinical studies can provide rich data for detailed mechanism-based modelling. While similar sampling techniques are limited in clinical studies, PK-PD models can be used to optimize the design of experiments to improve estimation of the parameters of interest. Ultimately, we propose that fully developed mechanistic models can simulate and rationalize ACT or other treatment strategies in antimalarial chemotherapy. |
[
right
kwic]
(1)62  were |
(15)5 participated |
(29)2 Basic |
(43)2 read |
| (2)53 had |
(16)5 sexually |
(30)2 believed |
(44)2 require |
| (3)25 are |
(17)4 do |
(31)2 can |
(45)2 required |
| (4)25 have |
(18)4 is |
(32)2 commuted |
(46)2 scored |
| (5)25 underwent |
(19)4 responded |
(33)2 consumed |
(47)2 showed |
| (6)21 received |
(20)4 sought |
(34)2 deal |
(48)2 smoked |
| (7)14 presented |
(21)3 attended |
(35)2 died |
(49)2 struggle |
| (8)13 developed |
(22)3 has |
(36)2 experience |
(50)2 suffered |
| (9)11 reported |
(23)3 in |
(37)2 had, |
(51)2 sustained |
| (10)11 was |
(24)3 lived |
(38)2 live |
(52)2 took |
| (11)10 completed |
(25)3 may |
(39)2 lives |
(53)2 use |
| (12)10 experienced |
(26)3 met |
(40)2 measured |
(54)2 wanted |
| (13)8 did |
(27)3 work |
(41)2 participate |
|
| (14)5 inject |
(28)3 would |
(42)2 present |
add keyword
--- WordNet output for who ---